Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system

Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system

BackgroundPlecanatide is a selective gastrointestinal peptide used for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Given its widespread use, understanding the long-term safety of plecanatide in real-world settings is essential.Method...

Full description

Bibliographic Details
Main Authors: Zhiyuan Zhang, Yifan Yao, Li Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Pharmacology
Subjects:
plecanatide
disproportionality analysis
CIC
IBS-C
FAERS
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1500810/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1500810/full

Similar Items